177 related articles for article (PubMed ID: 9660980)
21. Properties of mutant SHV-5 beta-lactamases constructed by substitution of isoleucine or valine for methionine at position 69.
Giakkoupi P; Miriagou V; Gazouli M; Tzelepi E; Legakis NJ; Tzouvelekis LS
Antimicrob Agents Chemother; 1998 May; 42(5):1281-3. PubMed ID: 9593168
[TBL] [Abstract][Full Text] [Related]
22. beta-Lactam resistance phenotype determination in Escherichia coli isolates from University Malaya Medical Centre.
Wong JS; Mohd Azri ZA; Subramaniam G; Ho SE; Palasubramaniam S; Navaratnam P
Malays J Pathol; 2003 Dec; 25(2):113-9. PubMed ID: 16196367
[TBL] [Abstract][Full Text] [Related]
23. Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors.
Helfand MS; Taracila MA; Totir MA; Bonomo RA; Buynak JD; van den Akker F; Carey PR
Biochemistry; 2007 Jul; 46(29):8689-99. PubMed ID: 17595114
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.
Blazquez J; Baquero MR; Canton R; Alos I; Baquero F
Antimicrob Agents Chemother; 1993 Oct; 37(10):2059-63. PubMed ID: 8257123
[TBL] [Abstract][Full Text] [Related]
25. Resistance to beta-lactamase inhibitor protein does not parallel resistance to clavulanic acid in TEM beta-lactamase mutants.
Schroeder WA; Locke TR; Jensen SE
Antimicrob Agents Chemother; 2002 Nov; 46(11):3568-73. PubMed ID: 12384366
[TBL] [Abstract][Full Text] [Related]
26. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.
Petrosino JF; Palzkill T
J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154
[TBL] [Abstract][Full Text] [Related]
27. Mutagenesis of amino acid residues in the SHV-1 beta-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance.
Hujer AM; Hujer KM; Bonomo RA
Biochim Biophys Acta; 2001 May; 1547(1):37-50. PubMed ID: 11343789
[TBL] [Abstract][Full Text] [Related]
28. Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme.
Lin S; Thomas M; Shlaes DM; Rudin SD; Knox JR; Anderson V; Bonomo RA
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):395-400. PubMed ID: 9735103
[TBL] [Abstract][Full Text] [Related]
29. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
Gatermann S; Marre R
Infection; 1991; 19(2):106-9. PubMed ID: 1646771
[TBL] [Abstract][Full Text] [Related]
30. Elucidating the role of Trp105 in the KPC-2 β-lactamase.
Papp-Wallace KM; Taracila M; Wallace CJ; Hujer KM; Bethel CR; Hornick JM; Bonomo RA
Protein Sci; 2010 Sep; 19(9):1714-27. PubMed ID: 20662006
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.
Waltner-Toews RI; Paterson DL; Qureshi ZA; Sidjabat HE; Adams-Haduch JM; Shutt KA; Jones M; Tian GB; Pasculle AW; Doi Y
Antimicrob Agents Chemother; 2011 Feb; 55(2):495-501. PubMed ID: 21135189
[TBL] [Abstract][Full Text] [Related]
32. Novel mechanisms of resistance to β-lactam antibiotics in Haemophilus parainfluenzae: β-lactamase-negative ampicillin resistance and inhibitor-resistant TEM β-lactamases.
García-Cobos S; Arroyo M; Campos J; Pérez-Vázquez M; Aracil B; Cercenado E; Orden B; Lara N; Oteo J
J Antimicrob Chemother; 2013 May; 68(5):1054-9. PubMed ID: 23335113
[TBL] [Abstract][Full Text] [Related]
33. Effects of Asp-179 mutations in TEMpUC19 beta-lactamase on susceptibility to beta-lactams.
Vakulenko SB; Tóth M; Taibi P; Mobashery S; Lerner SA
Antimicrob Agents Chemother; 1995 Aug; 39(8):1878-80. PubMed ID: 7486939
[TBL] [Abstract][Full Text] [Related]
34. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
Vanjak D; Muller-Serieys C; Picard B; Bergogne-Berezin E; Lambert-Zechovsky N
Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448
[TBL] [Abstract][Full Text] [Related]
35. Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.
Thomson KS; Weber DA; Sanders CC; Sanders WE
Antimicrob Agents Chemother; 1990 Apr; 34(4):622-7. PubMed ID: 2344169
[TBL] [Abstract][Full Text] [Related]
36. TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5).
Robin F; Delmas J; Chanal C; Sirot D; Sirot J; Bonnet R
Antimicrob Agents Chemother; 2005 Nov; 49(11):4443-7. PubMed ID: 16251281
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a PSE-4 mutant with different properties in relation to penicillanic acid sulfones: importance of residues 216 to 218 in class A beta-lactamases.
Sabbagh Y; Thériault E; Sanschagrin F; Voyer N; Palzkill T; Levesque RC
Antimicrob Agents Chemother; 1998 Sep; 42(9):2319-25. PubMed ID: 9736556
[TBL] [Abstract][Full Text] [Related]
38. Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation.
Giakkoupi P; Tzelepi E; Tassios PT; Legakis NJ; Tzouvelekis LS
J Antimicrob Chemother; 2000 Jan; 45(1):101-4. PubMed ID: 10629019
[TBL] [Abstract][Full Text] [Related]
39. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.
Zhou XY; Bordon F; Sirot D; Kitzis MD; Gutmann L
Antimicrob Agents Chemother; 1994 May; 38(5):1085-9. PubMed ID: 8067742
[TBL] [Abstract][Full Text] [Related]
40. Amino acid sequence requirements at residues 69 and 238 for the SME-1 beta-lactamase to confer resistance to beta-lactam antibiotics.
Majiduddin FK; Palzkill T
Antimicrob Agents Chemother; 2003 Mar; 47(3):1062-7. PubMed ID: 12604542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
